Clinical Trial: Recombinant Human Lactoferrin Administered Orally for the Prevention of Antibiotic Associated Diarrhea in Adult Patients

Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional

Official Title: A Phase III Randomized, Double Blind, Placebo Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Recombinant Human Lactoferrin Administered Orally for the Prevention of Antibiotic As

Brief Summary: The purpose of the study is to Evaluate the Efficacy and Safety of Recombinant Human Lactoferrin Administered Orally for the Prevention of Antibiotic Associated Diarrhea in Adult Patients.

Detailed Summary:
Sponsor: Ventria Bioscience

Current Primary Outcome: Reduction in the number of days of antibiotic associated diarrhea during the treatment period

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Ventria Bioscience

Dates:
Date Received: June 21, 2011
Date Started: September 2011
Date Completion: March 2014
Last Updated: June 23, 2011
Last Verified: June 2011